Quote
409.85
+9.12 (+2.28%)
We have scored 62 news catalysts on HUM (HUM) over the past 12 months. Coverage across the window leans mixed (average ticker sentiment −0.05). Most of the impact sits in sector healthcare and price momentum.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
401.17–410.99
Open
405.92
Prev close
400.73
Volume
682.5K
Avg volume
—
Dividend
—
IPO
—
No scored news tagged HUM or its network in the window yet.
Show more HUM articles →Analysts publish price targets on HUM, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
26 analyst price targets from $217 to $513
as of 2026-09-01
The market is within 5% of the median target — broadly agreeing with the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about HUM — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of HUM, taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for HUM: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The price sits near the median of 26 published models, agreeing with the endorsed consensus that the company will recover, but it explicitly rejects the 34% upside of the bull case and the 35% downside of the bear case.
What the disagreement turns on
Whether Humana can actually deliver its targeted 3% pretax margin by 2028 despite lower Star Ratings and high pharmacy costs, a question that wired unit volume data can partially answer by tracking membership retention after the 600,000 planned plan exits.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
Computed at $383 on 2026-09-01 — the quote has since moved +7%, so read this as a record of what was priced in then, not now.
